Abbvie Inc.
A global biopharmaceutical company, AbbVie develops and sells medicines for immune, nerve, and cancer conditions — brands include Skyrizi, Rinvoq, Humira, Botox, and Imbruvica — as well as cosmetic treatments like Botox Cosmetic and the Juvederm line. It was born in 2013 when Abbott Laboratories split, spinning off its drug business into a fresh company. Fun fact: the name blends "Abb" (from Abbott) with "Vie," echoing the Latin word for "life," and insiders noted it conveniently rhymes with "R&D."
Granted 1.1K
Granted 1.1K
Granted 1.1K
Granted 1.1K
Granted 1.1K
Granted 1.1K
Granted 1.1K
Sold 18.7K
Granted 1.1K
Granted 1.1K
Granted 1.1K
Granted 1.1K
Sold 5.2K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Freyman Thomas CDirector · 1 transaction | +0.8% | 133.8K | 1.1K | — | — |
| Rapp Edward JDirector · 1 transaction | +25.7% | 56.4K | 1.1K | — | — |
| Austin Roxanne SDirector · 1 transaction | +2.9% | 39.6K | 1.1K | — | — |
| Waddell Frederick HDirector · 1 transaction | +3.9% | 30.1K | 1.1K | — | — |
| Burnside William H.L.Director · 1 transaction | +4.1% | 28.1K | 1.1K | — | — |
| Hart Brett JDirector · 1 transaction | +5.7% | 20.6K | 1.1K | — | — |
| Meyer Melody BDirector · 1 transaction | +6.8% | 17.6K | 1.1K | — | — |
| Siatis Perry CEVP, GC AND SECRETARY · 3 transactions | -24.8% | 17.5K | — | — | 18.7K |
| Roberts Rebecca BDirector · 1 transaction | +8.1% | 14.8K | 1.1K | — | — |
| Falk Thomas JDirector · 1 transaction | +26.6% | 5.3K | 1.1K | — | — |
| Davis Jennifer L.Director · 1 transaction | +44.3% | 3.6K | 1.1K | — | — |
| Quaggin Susan EDirector · 1 transaction | +44.3% | 3.6K | 1.1K | — | — |
| Purdue David RyanSVP, Controller · 1 transaction | -87.9% | 1.1K | — | — | 5.2K |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 6 months: -23.9K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.